The FDA approved Bizengri, a new drug to treat cholangiocarcinoma, an ultra-rare and aggressive bile duct cancer. This breakthrough offers hope for patients with limited treatment options.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
FDA green lights Bizengri drug to treat rare, aggressive bile duct cancer
Cholangiocarcinoma (Bile Duct Cancer) Cancer type
Ultra-Rare Disease Rarity level
Bizengri Drug name
U.S. FDA Regulatory body